(Q33958706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

review article

1 reference

title

Gabapentin: pharmacology and its use in pain management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

P C A Kam

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Anaesthesia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

451-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11966555%20AND%20SRC:MED&resulttype=core&format=json

Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Characterization of the effects of gabapentin and 3-isobutyl-gamma-aminobutyric acid on substance P-induced thermal hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

A summary of mechanistic hypotheses of gabapentin pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Excitatory amino acid receptors in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Monotherapy trials with gabapentin for partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Use of gabapentin in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin prevents hyperalgesia during the formalin test in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

The effect of gabapentin on neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Acute and chronic pain syndromes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Open label gabapentin treatment for pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Reflex sympathetic dystrophy treated with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Effectiveness of gabapentin in controlling spasticity: a quantitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin treatment for muscle cramps: an open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Use of gabapentin to treat taxane-induced myalgias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Relief of anesthesia dolorosa with gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin for the treatment of dysesthetic pain after reconstructive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Gabapentin for self-injurious behavior in Lesch-Nyhan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0003-2409.2001.02399.X